Most cases of INAD are associated with homozygous or compound heterozygous mutations in the PLA2G6 gene that affect the catalytic activity of its protein product (Engel et al., 2010). This evidence concerns the gene PLA2G6 and neurodegeneration with brain iron accumulation 2A.